References
Works cited across the glossary and the traces, in APA (7th edition). Every in-text citation on the site links here and shows the full entry on hover or tap.
Abadie, A., Diamond, A., & Hainmueller, J. (2010). Synthetic control methods for comparative case studies: Estimating the effect of California’s tobacco control program. Journal of the American Statistical Association, 105(490), 493–505. https://doi.org/10.1198/jasa.2009.ap08746
ACCORD Study Group (2010). Effects of intensive blood-pressure control in type 2 diabetes mellitus. New England Journal of Medicine, 362(17), 1575–1585. https://doi.org/10.1056/NEJMoa1001286
Akaike, H. (1974). A new look at the statistical model identification. IEEE Transactions on Automatic Control, 19(6), 716–723. https://doi.org/10.1109/tac.1974.1100705
Angrist, J. D., Imbens, G. W., & Rubin, D. B. (1996). Identification of causal effects using instrumental variables. Journal of the American Statistical Association, 91(434), 444–455. https://doi.org/10.1080/01621459.1996.10476902
Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B: Statistical Methodology, 57(1), 289–300. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x
Bland, J. M., & Altman, D. G. (1986). Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet, 327(8476), 307–310. https://doi.org/10.1016/s0140-6736(86)90837-8
Bo, Y., Kwok, K. O., Chu, K. K. Y., Leung, E. Y. H., Yu, C. P., Wong, S. Y. S., & Lee, E. K. P. (2021). Comparison between automated office blood pressure measurements and manual office blood pressure measurements—Implications in individual patients: A systematic review and meta-analysis. Current Hypertension Reports, 23(1). https://doi.org/10.1007/s11906-020-01118-1
Breiman, L. (2001). Random forests. Machine Learning, 45(1), 5–32. https://doi.org/10.1023/a:1010933404324
Campbell, B. C. V., Mitchell, P. J., Churilov, L., Yassi, N., Kleinig, T. J., Dowling, R. J., Yan, B., Bush, S. J., Dewey, H. M., Thijs, V., Scroop, R., Simpson, M., Brooks, M., Asadi, H., Wu, T. Y., Shah, D. G., Wijeratne, T., Ang, T., Miteff, F., … Davis, S. M. (2018). Tenecteplase versus alteplase before thrombectomy for ischemic stroke. New England Journal of Medicine, 378(17), 1573–1582. https://doi.org/10.1056/NEJMoa1716405
Campbell, B. C. V., Mitchell, P. J., Churilov, L., Yassi, N., Kleinig, T. J., Dowling, R. J., Yan, B., Bush, S. J., Thijs, V., Scroop, R., Simpson, M., Brooks, M., Asadi, H., Wu, T. Y., Shah, D. G., Wijeratne, T., Zhao, H., Alemseged, F., Ng, F., … D’Este, C. (2020). Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke. JAMA, 323(13), 1257. https://doi.org/10.1001/jama.2020.1511
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of chronic diseases, 40(5), 373–83. https://doi.org/10.1016/0021-9681(87)90171-8
Cohen, J. (1960). A coefficient of agreement for nominal scales. Educational and Psychological Measurement, 20(1), 37–46. https://doi.org/10.1177/001316446002000104
Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16(3), 297–334. https://doi.org/10.1007/bf02310555
DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177–188. https://doi.org/10.1016/0197-2456(86)90046-2
Dias, S., Welton, N. J., Caldwell, D. M., & Ades, A. E. (2010). Checking consistency in mixed treatment comparison meta‐analysis. Statistics in Medicine, 29(7-8), 932–944. https://doi.org/10.1002/sim.3767
Dimick, J. B., & Ryan, A. M. (2014). Methods for evaluating changes in health care policy: The difference-in-differences approach. JAMA, 312(22), 2401–2. https://doi.org/10.1001/jama.2014.16153
Efron, B. (1979). Bootstrap methods: Another look at the jackknife. The Annals of Statistics, 7(1). https://doi.org/10.1214/aos/1176344552
Elixhauser, A., Steiner, C., Harris, D. R., & Coffey, R. M. (1998). Comorbidity measures for use with administrative data. Medical care, 36(1), 8–27. https://doi.org/10.1097/00005650-199801000-00004
Farrington, C. P. (1995). Relative incidence estimation from case series for vaccine safety evaluation. Biometrics, 51(1), 228–35.
Fine, J. P., & Gray, R. J. (1999). A proportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association, 94(446), 496–509. https://doi.org/10.1080/01621459.1999.10474144
Hernán, M. A., & Robins, J. M. (2016). Using big data to emulate a target trial when a randomized trial is not available. American Journal of Epidemiology, 183(8), 758–764. https://doi.org/10.1093/aje/kwv254
Johnson, K. C., Whelton, P. K., Cushman, W. C., Cutler, J. A., Evans, G. W., Snyder, J. K., Ambrosius, W. T., Beddhu, S., Cheung, A. K., Fine, L. J., Lewis, C. E., Rahman, M., Reboussin, D. M., Rocco, M. V., Oparil, S., & Wright, J. T. (2018). Blood pressure measurement in SPRINT (Systolic blood pressure intervention trial). Hypertension, 71(5), 848–857. https://doi.org/10.1161/HYPERTENSIONAHA.117.10479
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988). An assessment of clinically useful measures of the consequences of treatment. The New England journal of medicine, 318(26), 1728–33. https://doi.org/10.1056/nejm198806303182605
Logallo, N., Novotny, V., Assmus, J., Kvistad, C. E., Alteheld, L., Rønning, O. M., Thommessen, B., Amthor, K. F., Ihle-Hansen, H., Kurz, M., Tobro, H., Kaur, K., Stankiewicz, M., Carlsson, M., Morsund, Idicula, T., Aamodt, A. H., Lund, C., Næss, H., … Thomassen, L. (2017). Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): A phase 3, randomised, open-label, blinded endpoint trial. The Lancet Neurology, 16(10), 781–788. https://doi.org/10.1016/S1474-4422(17)30253-3
Menon, B. K., Buck, B. H., Singh, N., Deschaintre, Y., Almekhlafi, M. A., Coutts, S. B., Thirunavukkarasu, S., Khosravani, H., Appireddy, R., Moreau, F., Gubitz, G., Tkach, A., Catanese, L., Dowlatshahi, D., Medvedev, G., Mandzia, J., Pikula, A., Shankar, J., Williams, H., … Aljundi, Z. E. (2022). Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): A pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. The Lancet, 400(10347), 161–169. https://doi.org/10.1016/S0140-6736(22)01054-6
Muir, K. W., Ford, G. A., Ford, I., Wardlaw, J. M., McConnachie, A., Greenlaw, N., Mair, G., Sprigg, N., Price, C. I., MacLeod, M. J., Dima, S., Venter, M., Zhang, L., O’Brien, E., Sanyal, R., Reid, J., Sztriha, L. K., Haider, S., Whiteley, W. N., … ATTEST-2 Investigators (2024). Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): A randomised, parallel group, open-label trial. The Lancet Neurology, 23(11), 1087–1096. https://doi.org/10.1016/S1474-4422(24)00377-6
O’Quigley, J., Pepe, M., & Fisher, L. (1990). Continual reassessment method: A practical design for phase 1 clinical trials in cancer. Biometrics, 46(1), 33. https://doi.org/10.2307/2531628
Pocock, S. J., & Simon, R. (1975). Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics, 31(1), 103. https://doi.org/10.2307/2529712
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., Jauch, E. C., Kidwell, C. S., Leslie-Mazwi, T. M., Ovbiagele, B., Scott, P. A., Sheth, K. N., Southerland, A. M., Summers, D. V., Tirschwell, D. L., & American Heart Association Stroke Council (2019). Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 50(12). https://doi.org/10.1161/STR.0000000000000211
Prabhakaran, S., Gonzalez, N. R., Zachrison, K. S., Adeoye, O., Alexandrov, A. W., Ansari, S. A., Chapman, S., Czap, A. L., Dumitrascu, O. M., Ishida, K., Jadhav, A. P., Johnson, B., Johnston, K. C., Khatri, P., Kimberly, W. T., Lee, V. H., Leslie-Mazwi, T. M., Mac Grory, B., Madsen, T. E., … Yaghi, S. (2026). 2026 guideline for the early management of patients with acute ischemic stroke: A guideline from the American Heart Association/American Stroke Association. Stroke. Advance online publication. https://doi.org/10.1161/STR.0000000000000513
Robins, J. M., & Greenland, S. (1992). Identifiability and exchangeability for direct and indirect effects. Epidemiology (Cambridge, Mass.), 3(2), 143–55. https://doi.org/10.1097/00001648-199203000-00013
Robins, J. M., Hernán, M. A., & Brumback, B. (2000). Marginal structural models and causal inference in epidemiology. Epidemiology (Cambridge, Mass.), 11(5), 550–60. https://doi.org/10.1097/00001648-200009000-00011
Rose, D., Cavalier, A., Kam, W., Cantrell, S., Lusk, J., Schrag, M., Yaghi, S., Stretz, C., de Havenon, A., Saldanha, I. J., Wu, T. Y., Ranta, A., Barber, P. A., Marriott, E., Feng, W., Kosinski, A. S., Laskowitz, D., Poli, S., & Mac Grory, B. (2023). Complications of intravenous tenecteplase versus alteplase for the treatment of acute ischemic stroke: A systematic review and meta-analysis. Stroke, 54(5), 1192–1204. https://doi.org/10.1161/STROKEAHA.122.042335
Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. https://doi.org/10.1093/biomet/70.1.41
Royston, P., & Parmar, M. K. (2013). Restricted mean survival time: An alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome. BMC Medical Research Methodology, 13(1). https://doi.org/10.1186/1471-2288-13-152
Rubin, D. B. (1976). Inference and missing data. Biometrika, 63(3), 581–592. https://doi.org/10.1093/biomet/63.3.581
Salanti, G., Ades, A. E., & Ioannidis, J. P. (2011). Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: An overview and tutorial. Journal of clinical epidemiology, 64(2), 163–71. https://doi.org/10.1016/j.jclinepi.2010.03.016
Shrout, P. E., & Fleiss, J. L. (1979). Intraclass correlations: Uses in assessing rater reliability. Psychological Bulletin, 86(2), 420–428. https://doi.org/10.1037/0033-2909.86.2.420
Simon, R. (1989). Optimal two-stage designs for phase II clinical trials. Controlled clinical trials, 10(1), 1–10. https://doi.org/10.1016/0197-2456(89)90015-9
Singh, A., Singh, M. P., Gaikwad, N. R., & Kannauje, P. K. (2024). Tenecteplase versus alteplase in acute ischemic stroke: A systematic review and meta-analysis. Annals of Neurosciences, 31(2), 132–142. https://doi.org/10.1177/09727531231193242
The SPRINT Research Group (2015). A randomized trial of intensive versus standard blood-pressure control. New England Journal of Medicine, 373(22), 2103–2116. https://doi.org/10.1056/NEJMoa1511939
The SPRINT Research Group (2021). Final report of a trial of intensive versus standard blood-pressure control. New England Journal of Medicine, 384(20), 1921–1930. https://doi.org/10.1056/NEJMoa1901281
Thistlethwaite, D. L., & Campbell, D. T. (1960). Regression-discontinuity analysis: An alternative to the ex post facto experiment. Journal of Educational Psychology, 51(6), 309–317. https://doi.org/10.1037/h0044319
Tibshirani, R. (1996). Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society Series B: Statistical Methodology, 58(1), 267–288. https://doi.org/10.1111/j.2517-6161.1996.tb02080.x
van der Laan, M. J., & Rubin, D. (2006). Targeted maximum likelihood learning. The International Journal of Biostatistics, 2(1). https://doi.org/10.2202/1557-4679.1043
VanderWeele, T. J., & Ding, P. (2017). Sensitivity analysis in observational research: Introducing the E-value. Annals of Internal Medicine, 167(4), 268–274. https://doi.org/10.7326/m16-2607
Vickers, A. J., & Elkin, E. B. (2006). Decision curve analysis: A novel method for evaluating prediction models. Medical decision making : an international journal of the Society for Medical Decision Making, 26(6), 565–74. https://doi.org/10.1177/0272989x06295361
Wang, Y., Li, S., Pan, Y., Li, H., Parsons, M. W., Campbell, B. C. V., Schwamm, L. H., Fisher, M., Che, F., Dai, H., Li, D., Li, R., Wang, J., Wang, Y., Zhao, X., Li, Z., Zheng, H., Xiong, Y., Meng, X., & TRACE-2 Investigators (2023). Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): A phase 3, multicentre, open-label, randomised controlled, non-inferiority trial. The Lancet, 401(10377), 645–654. https://doi.org/10.1016/S0140-6736(22)02600-9
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., MacLaughlin, E. J., Muntner, P., Ovbiagele, B., Smith, S. C., Spencer, C. C., Stafford, R. S., Taler, S. J., Thomas, R. J., Williams, K. A., … Wright, J. T. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension, 71(6). https://doi.org/10.1161/HYP.0000000000000065
Yao, B., Wang, X., Wu, Y., Zhu, Q., Li, L., Tang, X., & Wu, M. (2025). Tenecteplase versus alteplase for intravenous thrombolysis of acute ischemic stroke patients with large-vessel occlusion: A systematic review and meta-analysis. Frontiers in Neurology, 16. https://doi.org/10.3389/fneur.2025.1487711